In vivo use of water absorbent polymers
View Patent ↗The subject invention is a method and material for removing fluid from the intestinal tract of a host and may be useful in treating animals or human patients suffering from fluid overload states. In one embodiment, the subject method involves ingesting an enterically coated non-systemic, non-toxic, non-digestible, water absorbing polymer which absorbs fluid while passing through the intestinal tract. The polymer is excreted in the feces wherein the polymer and absorbed fluid is removed from the body. Preferred polymers include super absorbent acrylic acid polymers, preferably provided in bead form. The polymers may include functional groups for selectively removing blood borne waste products, e.g. urea, from the G.I. tract.
1. A method for treating a fluid overload state in a patient in need thereof, the method comprising directly delivering to the intestinal tract of the host an effective amount of a water-absorbent polymer, wherein the water-absorbent polymer is capable of absorbing at least 10 times its weight in physiological saline, wherein the water-absorbent polymer is not directly exposed to the stomach prior to delivery to the intestinal tract and wherein the fluid overload stat is congestive heart failure, cirrhosis of the liver, nephrosis, ascites, renal disease, edema associated with chemotherapy, pre-menstrual fluid overload, or preeclampsia.
2. The method of claim 1 , wherein the polymer is enterically coated and the method of delivery is oral administration.
3. The method of claim 1 , wherein the polymer is capable of absorbing at least 20 times its weight in physiological saline.
4. The method of claim 1 , wherein the polymer is capable of absorbing at least 30 times its weight in physiological saline.
5. The method of claim 1 , wherein the polymer is capable of absorbing at least 40 times its weight in physiological saline.
6. The method of claim 1 , wherein the polymer is formed by polymerizing acrylate containing monomers.
7. The method of claim 1 , wherein the polymer is formed by polymerizing a monomer comprising acrylic acid or salts thereof.
8. The method of claim 1 , wherein the polymer is a polysaccharide.
9. The method of claim 1 , wherein the polymer is enterically coated and the enteric coating is selected from at least one of hydroxypropylmethylcellulose, hydroxypropylmethylcellulose phthalate, methacrylic acid polymers, or polymers of derivatives of methacrylic acid.
10. The method of claim 1 , wherein the polymer is placed within an enterically coated capsule.
11. The method of claim 1 , wherein the polymer is placed within an enterically coated capsule and the enteric coating is selected from at least one of: hydroxypropylmethylcellulose, hydroxypropylmethylcellulose phthalate, methacrylic acid polymers, or polymers of derivatives of methacrylic acid.
12. The method according to claim 1 , wherein the fluid overload state is renal disease.
13. The method of claim 1 , wherein the fluid overload state is congestive heart failure.